Lista de obras - Mark F. Lew - Dominio Público Uruguay

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia

artículo científico publicado en 2018

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease

artículo científico publicado en 2016

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

artículo científico

A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.

artículo científico publicado en 2017

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease

artículo científico publicado en 2001

Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers

artículo científico publicado en 2012

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

artículo científico publicado en 2016

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia ⬇️

artículo científico publicado el 1 de septiembre de 1997

Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective

artículo científico publicado en 2016

Clozapine treatment of parkinsonism with psychosis

artículo científico publicado en 1993

Complete ascertainment of Parkinson disease in the Swedish Twin Registry

artículo científico publicado en 2007

Current and emerging treatments for cervical dystonia

scientific article published on 01 June 2000

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

artículo científico publicado en 2015

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

artículo científico publicado en 2002

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study

artículo científico publicado en 2005

Genome-wide scan for Parkinson's disease: the GenePD Study

artículo científico publicado en 2001

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study

artículo científico publicado en 2008

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study

article

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study

artículo científico publicado en 2008

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study

artículo científico publicado en 2010

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study

artículo científico publicado en 2006

Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials

artículo científico publicado en 2015

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials

artículo científico publicado en 2015

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results

artículo científico publicado en 2014

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

scientific article published on 31 March 2010

Long-term efficacy of rasagiline in early Parkinson's disease

artículo científico publicado en 2010

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

artículo científico publicado en 2009

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease

scientific article published on 23 March 2018

Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's disease

scientific article published on 19 January 2011

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

artículo científico publicado en 2017

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects

artículo científico publicado en 2010

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

artículo científico publicado en 2002

Poster 290 Efficacy and Safety of a 2 mL Dilution of AbobotulinumtoxinA Compared with Placebo in Adult Patients with Cervical Dystonia

artículo científico publicado en 2016

Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor

scientific article published on 14 August 2020

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

artículo científico publicado en 1998

Replication of association between ELAVL4 and Parkinson disease: the GenePD study

artículo científico publicado en 2008

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

artículo científico publicado en 2017

Role of botulinum toxin in the treatment of cervical dystonia

artículo científico publicado en 2008

Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial

scientific article published on 13 January 2020

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 01 February 2019

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

artículo científico publicado en 1999

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

artículo científico publicado en 1999

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease

artículo científico publicado en 2007

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

artículo científico publicado en 2008

The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.

artículo científico publicado en 2000

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial

artículo científico publicado en 2014

Ventroposterior Medial Pallidotomy in Patients with Advanced Parkinson's Disease ⬇️

artículo científico publicado el 1 de junio de 1995

Lista de obras de Mark F. Lew

A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia

A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit

A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease

Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease

Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia ⬇️

Clinical utility of DaTscan™ imaging in the evaluation of patients with parkinsonism: a US perspective

Clozapine treatment of parkinsonism with psychosis

Complete ascertainment of Parkinson disease in the Swedish Twin Registry

Current and emerging treatments for cervical dystonia

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study

Genome-wide scan for Parkinson's disease: the GenePD Study

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: The GenePD Study

Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study

Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study

Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials

Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials

Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results

Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia

Long-term efficacy of rasagiline in early Parkinson's disease

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease

Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease

Long-term, open-label study of once-daily ropinirole prolonged release in early Parkinson's disease

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects

PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study

Poster 290 Efficacy and Safety of a 2 mL Dilution of AbobotulinumtoxinA Compared with Placebo in Adult Patients with Cervical Dystonia

Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor

Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III.

Replication of association between ELAVL4 and Parkinson disease: the GenePD study

RimabotulinumtoxinB in sialorrhea: systematic review of clinical trials

Role of botulinum toxin in the treatment of cervical dystonia

Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia

Safety and efficacy of newly formulated selegiline orally disintegrating tablets as an adjunct to levodopa in the management of 'off' episodes in patients with Parkinson's disease

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials.

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial

Ventroposterior Medial Pallidotomy in Patients with Advanced Parkinson's Disease ⬇️